Skip to content

Multi-center and Multi-modal Deep Learning Study of Gastric Cancer

Multi-center and Multi-modal Deep Learning Study of Diagnosis, Therapeutic Outcome and Prognosis of Gastric Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05001321
Enrollment
3300
Registered
2021-08-11
Start date
2021-07-01
Completion date
2024-12-31
Last updated
2021-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach Neoplasms

Keywords

Diagnosis, Prognosis

Brief summary

To assist postoperative pathological diagnosis and classification of gastric cancer by machine learning; To improve the accuracy of pathological diagnosis of gastric cancer by machine learning; To predict the effectiveness of treatment for gastric cancer by deep learning; To construct a model to predict the survival of gastric cancer patients by multimodal deep learning.

Interventions

RADIATIONThe whole abdomen contrast-enhanced CT scan

All the participants were measured by the whole abdomen contrast-enhanced CT scan.

OTHERH&E stained sections and slides

HE pathological examination was performed on all specimens of enrolled patients.

Sponsors

The Second Hospital of Shandong University
CollaboratorOTHER
Chaoyang Central Hospital
CollaboratorOTHER
The General Hospital of Fushun Mining Bureau
CollaboratorUNKNOWN
The fourth People's Hospital of Changzhou
CollaboratorUNKNOWN
First Hospital of Jinzhou Medical University
CollaboratorUNKNOWN
First Hospital of China Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* The diagnosis of gastric cancer was confirmed by pathology; * Preoperative enhanced abdominal CT; * Available detailed clinical and pathological data; * Integrated follow-up data.

Exclusion criteria

* The patients had severe underlying disease; * Overall survival was less than 3 months; * No detailed information could be collected.

Design outcomes

Primary

MeasureTime frameDescription
Texture of nuclei1 dayTo obtain the texture of nuclei of postoperative H&E stained sections and slides of gastric cancer by deep learning.
Nucleus size1 dayTo obtain the nucleus size of postoperative H&E stained sections and slides of gastric cancer by deep learning.
Nucleus shape1 dayTo obtain the nucleus shape of postoperative H&E stained sections and slides of gastric cancer by deep learning.
Distribution of pixel intensity1 dayTo obtain the distribution of pixel intensity of postoperative H&E stained sections and slides of gastric cancer by deep learning.
Maximum diameter of tumor1 dayTo measure the maximum diameter of tumor on preoperative enhanced abdominal CT of patients with gastric cancer.
Growth pattern1 dayTo assess the growth pattern on preoperative enhanced abdominal CT of patients with gastric cancer, including endophytic, exophytic and mixed.
Enhancement pattern1 dayTo assess the enhancement pattern on preoperative enhanced abdominal CT of patients with gastric cancer, including homogeneous and heterogeneous.
Enhancement degree1 dayTo assess the enhancement degree on preoperative enhanced abdominal CT of patients with gastric cancer, including hypoenhancement, isoenhancement and hyperenhancement.

Secondary

MeasureTime frameDescription
Overall survival1 dayTo calculate the overall survival of patients with gastric cancer based on days to death and days to last follow-up.
Recurrence/metastasis1 dayTo calculate the days to recurrence/metastasis of patients with gastric cancer.
Survival status1 dayTo analyze the survival status of patients with gastric cancer, involving dead and alive.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026